Oncocyte

Website

Oncocyte Corp

12 Investors
Molecular Diagnostics
IRVINE, CA

Oncocyte Corporation is a leading molecular diagnostics company committed to enhancing patient outcomes through advanced diagnostic testing solutions tailored for oncology and transplant care. By focusing on delivering actionable insights, Oncocyte empowers healthcare professionals to make informed medical decisions critical to patient treatment pathways.

Products & Team

Molecular Diagnostic Tests

Diagnostic TestingSeed

Oncocyte develops a comprehensive range of molecular diagnostic tests that enable healthcare providers to obtain vital patient information necessary for informed treatment decisions. These tests are strategically designed to be integrated seamlessly at key intervals throughout the treatment continuum.

Value Proposition

The diagnostic tests provided by Oncocyte help address the complexities of medical decision-making by equipping clinicians with crucial insights that enhance treatment accuracy and patient outcomes, ultimately leading to potential reductions in overall healthcare expenditures.

Pain Points

Physicians often face challenges in accessing timely and actionable diagnostic information when making treatment decisions, which can hinder patient outcomes and increase healthcare costs.

Actionable diagnostic informationFocus on personalized insightsApplication across oncology and transplant medicineIntegration into clinical workflows
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
IRVINE, CA
Primary headquarters

Funding History

Total Raised:
$21.7M
E

Equity, Option to Acquire Offering

Closed
February 2025
$21.7M
Raised
Progress
100%
Raised
$21.7M
Target
$21.7M
#000149315225007952